Results 171 to 180 of about 2,921,111 (382)

Chinese Expert Consensus on Standardized Outpatient Management of Sarcopenia in the Elderly (2024)

open access: yesAGING MEDICINE, EarlyView.
In China, specific sarcopenia clinics are not sufficient for outpatients. This consensus combines the professional advice of domestic geriatrics experts, summarizes the existing domestic experience in the establishment of sarcopenia clinics, and provides guidance for the management of sarcopenia clinics.
Zhang Qin   +78 more
wiley   +1 more source

Risk Factors and Predictive Models for Sarcopenia in Older Adults

open access: yesAGING MEDICINE, EarlyView.
Independent risk factors for sarcopenia identified by Lasso regression and logistic regression in the study were BMI, prealbumin, albumin/globulin ratio (A/G ratio), serum creatinine, and phosphorus. These factors were used to construct a nomogram model and a decision tree model. Both models showed effectiveness in predicting sarcopenia in older adults,
Shiyuan Zhang   +9 more
wiley   +1 more source

EPI Update, June 22, 2007 [PDF]

open access: yes, 2007
Weekly newsletter for Center For Acute Disease Epidemiology of Iowa Department of Public ...

core  

Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management

open access: yesClinical Microbiology Reviews, 2015
S. Tong   +4 more
semanticscholar   +1 more source

Perioperative outcomes of esophagectomy after doublet versus docetaxel‐based triplet neoadjuvant chemotherapy in older patients: A nationwide inpatient database study in Japan

open access: yesAnnals of Gastroenterological Surgery, EarlyView.
In this nationwide inpatient database study of 5229 patients aged 70–79 years who underwent esophagectomy for cancer after neoadjuvant chemotherapy, overlap propensity score weighting analysis showed that neoadjuvant docetaxel‐based triplet regimen (docetaxel, cisplatin, and 5‐fluorouracil) was not associated with a higher incidence of perioperative ...
Yuki Hirano   +11 more
wiley   +1 more source

Clinical role of intraperitoneal chemotherapy in patients with pancreatic ductal adenocarcinoma concomitant with occult peritoneal dissemination: A multicenter retrospective study

open access: yesAnnals of Gastroenterological Surgery, EarlyView.
The effectiveness of intraperitoneal chemotherapy using paclitaxel (i.p.‐PTX) in pancreatic ductal adenocarcinoma (PDAC) patients with peritoneal dissemination remains elusive. This study indicated that the i.p.‐PTX therapy may improve survival in selected patients with PDAC, in particular those with occult peritoneal dissemination.
Tomohisa Yamamoto   +33 more
wiley   +1 more source

Home - About - Disclaimer - Privacy